Key facts
- Nami Surgical’s last known valuation is $7.5M (May 2024).
- It has raised $5.6M; the latest was Later Stage VC ($10.0M) in Jul 2025.
- Notable investors include Innovate UK, Scottish Enterprise, British Business Bank, Maven Capital Partners UK, UK Research and Innovation — 11 tracked in total.
- Nami Surgical has filed 1 Form D with the SEC, most recently May 2024 ($123K sold to 1 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Nami Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Nami Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nami Surgical
Developer of ultrasonic surgical tools designed to transform the current robotic-assisted surgery market. The company's tools provide simplified and safer robotic surgery procedures, expand the use of robots in surgeries requiring ultrasonic devices and enhance the clinical benefits of ultrasonic devices in robotic surgery, enabling patients with intuitive, high-performance, maneuverable tools for complex surgical tasks.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2021
- Employees
- 14
- Website
- namisurgical.com/
- Ownership
- Privately Held (backing)
Nami Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nami Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nami Surgical in its N-PORT filings yet. We sweep new filings monthly.